$WLK

Westlake’s (WLK) Second Quarter Turned Two Straight Losses Into Profit

Westlake (WLK) reported Q2 net income of $260M ($2.01/Share), reversing prior losses, driven by a 14% price increase in its chemicals segment. EBITDA tripled YoY. Housing segment margins slipped. Debt reduced by $500M, $99M returned to shareholders. Hedge funds increased holdings, but short interest remains high at 17.44%. Forward P/E is 15.02.

Original reporting
Published Sep 16, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 4:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Westlake’s (WLK) Second Quarter Turned Two Straight Losses Into Profit — source image
Decision brief

The 30-second read

$WLKBullishHigh
01

Why it matters

The earnings surprise may trigger buying pressure, but volatility could remain due to segment weakness and high short interest.

02

Market read

First‑report earnings beat for a mid‑cap chemical company, offering a clear trading catalyst.

03

What to watch

Housing segment margin compression and reliance on price hikes could limit sustainability.

Relevance 8/10Novelty 8/10Timing: recent Q2 earnings release

Background

Westlake's three‑pillar profitability plan aims to deliver $600M operating income benefit; debt reduction and cash returns were also highlighted.

Company-level read

Ticker impact

$WLKBullishHigh confidence
Context

Westlake reported Q2 net income of $260M, a swing from two prior quarters of losses, and a tripling of EBITDA.

Expected impact

Potential upside of 5‑10% as investors re‑price the earnings surprise.

Evidence & confidence

The company posted a sizable profit, reduced debt, and returned cash, while short interest remains high, indicating a catalyst for a bounce.

Market effects

Improves outlook for the chemicals/materials sector as a peer shows earnings recovery.

Positive for U.S. industrial stocks, especially mid‑cap chemical producers.

Limited to investors tracking U.S. materials companies.

Counterpoint

High short interest suggests risk of a reversal if pricing gains fade.

Key entities

  • Westlake Corporation

    U.S. chemicals producer (ticker WLK).

Related articles

$WLKHigh

Why is Westlake stock sliding today?

Westlake (WLK) stock fell 3.4% to $64.55 after announcing the permanent closure of its PVC plant in Cologne, Germany, and warning of weaker Q3 2026 performance. The closure will incur $205M in pre-tax charges, with $110M expected in 2026. The decision is due to challenging market conditions, including high energy costs and competition. The company also expects lower financial performance in Q3 2026 due to lower prices and higher freight costs.

$WLKHighAI 8/10

Westlake Corporation: Westlake to Optimize European Chlorovinyls Footprint with Closure of Cologne PVC Plant

Westlake Corporation (WLK) will close its PVC plant in Cologne, Germany, due to challenging market conditions. The company expects to record pre-tax charges of $205 million, with $110 million in 2026. The closure is expected to improve the profitability of its European chlorovinyl operations. Westlake anticipates lower financial performance in Q3 2026 compared to Q2 2026.

$WLKMedAI 8/10

Westlake to Optimize European Chlorovinyls Footprint with Closure of Cologne PVC Plant

WESTLAKE CORP (WLK) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Westlake to Optimize European Chlorovinyls Footprint with Closure of Cologne PVC Plant HOUSTON, September 29, 2026 — Westlake Corporation (NYSE: WLK) (“Westlake” or the “Company”) announced today that, in light of challenging market conditions, the Company is taking

$WLKMedAI 8/10

Westlake (WLK) Q2 2026 Earnings Call Transcript

Westlake (WLK) reported Q2 2026 net sales of $3.3 billion, up from $3.0 billion a year earlier, and EBITDA of $679 million versus $340 million. The company cited $150 million of 3-pillar plan benefits and guided full-year HIP revenue of $4.4 to $4.6 billion and HIP EBITDA margin of 19% to 21%. Debt was reduced by $500 million.